These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37102354)

  • 1. [ANMCO Position paper: Wearable cardioverter defibrillator appropriate use guidance for the management of patients at high transient risk of sudden cardiac death].
    Casolo G; Gulizia MM; Aschieri D; Chinaglia A; Corda M; Nassiacos D; Caico SI; Chimenti C; Giaccardi M; Gotti E; Maffè S; Magnano R; Solarino G; Gabrielli D; Oliva F; Colivicchi F
    G Ital Cardiol (Rome); 2023 May; 24(5):394-411. PubMed ID: 37102354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M; Weyand M; Seitz T; Harig F
    Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13048. PubMed ID: 36723848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?
    Israel C; Staudacher I; Leclercq C; Botto GL; Scherr D; Fach A; Duru F; Zylla MM; Katus HA; Thomas D
    Clin Res Cardiol; 2022 Nov; 111(11):1189-1197. PubMed ID: 35305126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: Clinical and economic implications.
    Boriani G; Mantovani LG; Cortesi PA; De Ponti R; D'Onofrio A; Arena G; Curnis A; Forleo G; Guerra F; Porcu M; Sgarito G; Botto GL
    Clin Cardiol; 2021 Nov; 44(11):1497-1505. PubMed ID: 34427926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I; Erath JW; Russo AM; Burch AE; Assmus B; Bonderman D; McNitt S; Kutyifa V
    Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patients with a wearable cardioverter-defibrillator (WCD) : Prescription, function and rehabilitation support].
    Schlitt A; Guha M; Noutsias M; Klein HH; Klein HU
    Herz; 2019 Aug; 44(5):379-389. PubMed ID: 29234842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM; Bense J; Hohenforst-Schmidt W
    J Interv Card Electrophysiol; 2021 Nov; 62(2):401-407. PubMed ID: 33200285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study.
    Garcia R; Combes N; Defaye P; Narayanan K; Guedon-Moreau L; Boveda S; Blangy H; Bouet J; Briand F; Chevalier P; Cottin Y; Da Costa A; Degand B; Deharo JC; Eschalier R; Extramiana F; Goralski M; Guy-Moyat B; Guyomar Y; Hermida JS; Jourda F; Lellouche N; Mahfoud M; Manenti V; Mansourati J; Martin A; Pasquié JL; Ritter P; Rollin A; Tibi T; Yalioua A; Gras D; Sadoul N; Piot O; Leclercq C; Marijon E
    Europace; 2021 Jan; 23(1):73-81. PubMed ID: 33257972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Wearable defibrillator : Current evidence].
    Duncker D; Veltmann C
    Herzschrittmacherther Elektrophysiol; 2018 Dec; 29(4):362-368. PubMed ID: 30357452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keeping up to date: a current review of wearable cardioverter defibrillator use.
    Ashraf S; Ilyas S; Siddiqui F; Ando T; Shokr M; Panaich S; Briasoulis A; Afonso L; Khan M
    Acta Cardiol; 2020 Dec; 75(8):695-704. PubMed ID: 31687917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
    Kaspar G; Sanam K; Gholkar G; Bianco NR; Szymkiewicz S; Shah D
    Int J Cardiol; 2018 Dec; 272():179-184. PubMed ID: 30121177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The wearable cardioverter-defibrillator vest: Indications and ongoing questions.
    Sandhu U; Rajyaguru C; Cheung CC; Morin DP; Lee BK
    Prog Cardiovasc Dis; 2019; 62(3):256-264. PubMed ID: 31077726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective.
    Botto GL; Mantovani LG; Cortesi PA; De Ponti R; D'Onofrio A; Biffi M; Capucci A; Casu G; Notarstefano P; Scaglione M; Zanotto G; Boriani G;
    Int J Cardiol; 2022 Jun; 356():12-18. PubMed ID: 35395289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world experience with the wearable cardioverter defibrillator: clinical effectiveness and wear-time adherence in patients at high risk for sudden cardiac death.
    Weth C; Abuazab H; Ewen S; Ukena C; Böhm M; Custodis F
    Herzschrittmacherther Elektrophysiol; 2022 Mar; 33(1):55-62. PubMed ID: 34694459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
    J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wearable cardioverter-defibrillators: A review of evidence and indications.
    Cheung CC; Olgin JE; Lee BK
    Trends Cardiovasc Med; 2021 Apr; 31(3):196-201. PubMed ID: 32205034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.
    Andresen H; Sasko B; Patschan D; Pagonas N; Ritter O
    J Med Case Rep; 2021 May; 15(1):243. PubMed ID: 33993888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS; Bianco NR; Knilans TK; Czosek RJ; Anderson JB
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006163. PubMed ID: 29945928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.